Skip to main content
Clinical Trials/NCT06396845
NCT06396845CompletedNot Applicable

Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)

Daorong Wang1 site in 1 country505 target enrollmentStarted: January 1, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
505
Locations
1
Primary Endpoint
postoperative recurrence rate

Study Overview

Brief Summary

This retrospective study collected participants who underwent robotic or laparoscopic anterior resection for rectal cancer at the North People's Hospital in Jiangsu from January 2019 to January 2023.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
55 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • The criteria include: (1) pathology of low rectal cancer (within 10 cm from the anal margin); (2) access to comprehensive pathological and computed tomography (CT) data; (3) completeness of clinical data.

Exclusion Criteria

  • patients with other malignant tumors besides rectal cancer, benign disease surgery, and emergency surgery.

Outcomes

Primary Outcomes

postoperative recurrence rate

Time Frame: 2018-2024

postoperative recurrence rate

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Daorong Wang
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Daorong Wang

DR

Northern Jiangsu People's Hospital

Study Sites (1)

Loading locations...

Similar Trials